Sonal Bhatia, Chief Medical Officer for rare disease at Pfizer, shares her insights on the groundbreaking role of AI in medical affairs. She discusses how AI tools are revolutionizing clinical practices and transforming patient outcomes by enhancing diagnostic accuracy and streamlining workflows. The conversation delves into AI's potential in drug development and clinical trials, highlighting its ability to identify rare disease patients and improve collaboration across medical teams. Get ready for an enlightening exploration of AI's future in healthcare!